Biotech Investing

Moleculin Biotech Reports Q3 2016 Financial Results

Biotech Investing

5 Top NASDAQ Biotech Stocks: Ocular Therapeutix Gains Near 60 Percent

Biotech Investing

Dynasil Joins with Cook Biotech to Advance Xcede Patch

Biotech Investing

Amgen and Novartis Lead the Migraine Market

Biotech Investing

BioSpecifics Technologies Reports Positive Data from Phase 2b Study of CCH

Biotech Investing

PharmAthene Declares Special Cash Dividend on Common Stock

Biotech Investing

Moleculin Receives Postive FDA Guidance for Annamycin IND

Biotech Investing

Regenicin Signs Supplier Agreement with Pure Med Farma

Biotech Investing

PDL BioPharma Prices Public Offering

Biotech Investing

Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate: UCART123

Biotech Investing

GTx Achieves Second Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm

Biotech Investing

GTx Achieves Second Stage 1 Milestone in Phase 2 Clinical Trial of Enobosarm

Biotech Investing

Latest biotech News

More biotech News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES